Guideline of guidelines: Testosterone therapy for testosterone deficiency Review


Authors: Salter, C. A.; Mulhall, J. P.
Review Title: Guideline of guidelines: Testosterone therapy for testosterone deficiency
Abstract: We analysed the guidelines for testosterone therapy (TTh) produced by major international medical societies including: the American Urological Association, European Association of Urology, American Association of Clinical Endocrinologists, British Society for Sexual Medicine, Endocrine Society, International Society for Sexual Medicine, and the International Society for the Study of the Aging Male, and compared their recommendations. All the organisations were in general agreement concerning the following key points: Only men meeting the criteria for testosterone deficiency (TD) should be treated. Consider screening asymptomatic men with certain conditions that increase the risk of TD. Exogenous TTh causes impairment of spermatogenesis. There is no evidence that TTh causes prostate cancer. Men on TTh require careful laboratory monitoring. © 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd
Keywords: fatigue; review; evidence based medicine; prostate specific antigen; anemia; clinical protocol; patient monitoring; practice guideline; bone density; cardiovascular risk; diabetes mellitus; hypogonadism; screening test; testosterone; androgen deficiency; androgen therapy; male infertility; spermatogenesis; asymptomatic disease; human; priority journal; testosterone therapy; testosterone deficiency
Journal Title: BJU International
Volume: 124
Issue: 5
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2019-11-01
Start Page: 722
End Page: 729
Language: English
DOI: 10.1111/bju.14899
PUBMED: 31420972
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John P Mulhall
    601 Mulhall
  2. Carolyn Anne Salter
    42 Salter